182 related articles for article (PubMed ID: 30389403)
1. Mice harbouring a SCA28 patient mutation in AFG3L2 develop late-onset ataxia associated with enhanced mitochondrial proteotoxicity.
Mancini C; Hoxha E; Iommarini L; Brussino A; Richter U; Montarolo F; Cagnoli C; Parolisi R; Gondor Morosini DI; Nicolò V; Maltecca F; Muratori L; Ronchi G; Geuna S; Arnaboldi F; Donetti E; Giorgio E; Cavalieri S; Di Gregorio E; Pozzi E; Ferrero M; Riberi E; Casari G; Altruda F; Turco E; Gasparre G; Battersby BJ; Porcelli AM; Ferrero E; Brusco A; Tempia F
Neurobiol Dis; 2019 Apr; 124():14-28. PubMed ID: 30389403
[TBL] [Abstract][Full Text] [Related]
2. Spinocerebellar Ataxia Type 28-Phenotypic and Molecular Characterization of a Family with Heterozygous and Compound-Heterozygous Mutations in AFG3L2.
Tunc S; Dulovic-Mahlow M; Baumann H; Baaske MK; Jahn M; Junker J; Münchau A; Brüggemann N; Lohmann K
Cerebellum; 2019 Aug; 18(4):817-822. PubMed ID: 31111429
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic variants in the AFG3L2 proteolytic domain cause SCA28 through haploinsufficiency and proteostatic stress-driven OMA1 activation.
Tulli S; Del Bondio A; Baderna V; Mazza D; Codazzi F; Pierson TM; Ambrosi A; Nolte D; Goizet C; Toro C; Baets J; Deconinck T; DeJonghe P; Mandich P; Casari G; Maltecca F
J Med Genet; 2019 Aug; 56(8):499-511. PubMed ID: 30910913
[TBL] [Abstract][Full Text] [Related]
4. Sustained OMA1-mediated integrated stress response is beneficial for spastic ataxia type 5.
Franchino CA; Brughera M; Baderna V; De Ritis D; Rocco A; Seneca S; Regal L; Podini P; D'Antonio M; Toro C; Quattrini A; Scalais E; Maltecca F
Brain; 2024 Mar; 147(3):1043-1056. PubMed ID: 37804316
[TBL] [Abstract][Full Text] [Related]
5. Whole-exome sequencing identifies homozygous AFG3L2 mutations in a spastic ataxia-neuropathy syndrome linked to mitochondrial m-AAA proteases.
Pierson TM; Adams D; Bonn F; Martinelli P; Cherukuri PF; Teer JK; Hansen NF; Cruz P; Mullikin For The Nisc Comparative Sequencing Program JC; Blakesley RW; Golas G; Kwan J; Sandler A; Fuentes Fajardo K; Markello T; Tifft C; Blackstone C; Rugarli EI; Langer T; Gahl WA; Toro C
PLoS Genet; 2011 Oct; 7(10):e1002325. PubMed ID: 22022284
[TBL] [Abstract][Full Text] [Related]
6. Expanding the phenotype of AFG3L2 mutations: Late-onset autosomal recessive spinocerebellar ataxia.
Chiang HL; Fuh JL; Tsai YS; Soong BW; Liao YC; Lee YC
J Neurol Sci; 2021 Sep; 428():117600. PubMed ID: 34333379
[TBL] [Abstract][Full Text] [Related]
7. Concurrent AFG3L2 and SPG7 mutations associated with syndromic parkinsonism and optic atrophy with aberrant OPA1 processing and mitochondrial network fragmentation.
Magri S; Fracasso V; Plumari M; Alfei E; Ghezzi D; Gellera C; Rusmini P; Poletti A; Di Bella D; Elia AE; Pantaleoni C; Taroni F
Hum Mutat; 2018 Dec; 39(12):2060-2071. PubMed ID: 30252181
[TBL] [Abstract][Full Text] [Related]
8. m-AAA proteases, mitochondrial calcium homeostasis and neurodegeneration.
Patron M; Sprenger HG; Langer T
Cell Res; 2018 Mar; 28(3):296-306. PubMed ID: 29451229
[TBL] [Abstract][Full Text] [Related]
9. Purkinje neuron Ca2+ influx reduction rescues ataxia in SCA28 model.
Maltecca F; Baseggio E; Consolato F; Mazza D; Podini P; Young SM; Drago I; Bahr BA; Puliti A; Codazzi F; Quattrini A; Casari G
J Clin Invest; 2015 Jan; 125(1):263-74. PubMed ID: 25485680
[TBL] [Abstract][Full Text] [Related]
10. Haploinsufficiency of AFG3L2, the gene responsible for spinocerebellar ataxia type 28, causes mitochondria-mediated Purkinje cell dark degeneration.
Maltecca F; Magnoni R; Cerri F; Cox GA; Quattrini A; Casari G
J Neurosci; 2009 Jul; 29(29):9244-54. PubMed ID: 19625515
[TBL] [Abstract][Full Text] [Related]
11. A novel AFG3L2 mutation close to AAA domain leads to aberrant OMA1 and OPA1 processing in a family with optic atrophy.
Baderna V; Schultz J; Kearns LS; Fahey M; Thompson BA; Ruddle JB; Huq A; Maltecca F
Acta Neuropathol Commun; 2020 Jun; 8(1):93. PubMed ID: 32600459
[TBL] [Abstract][Full Text] [Related]
12. Astrocyte-specific deletion of the mitochondrial m-AAA protease reveals glial contribution to neurodegeneration.
Murru S; Hess S; Barth E; Almajan ER; Schatton D; Hermans S; Brodesser S; Langer T; Kloppenburg P; Rugarli EI
Glia; 2019 Aug; 67(8):1526-1541. PubMed ID: 30989755
[TBL] [Abstract][Full Text] [Related]
13. AFG3L2 supports mitochondrial protein synthesis and Purkinje cell survival.
Almajan ER; Richter R; Paeger L; Martinelli P; Barth E; Decker T; Larsson NG; Kloppenburg P; Langer T; Rugarli EI
J Clin Invest; 2012 Nov; 122(11):4048-58. PubMed ID: 23041622
[TBL] [Abstract][Full Text] [Related]
14. Missense mutations in the AFG3L2 proteolytic domain account for ∼1.5% of European autosomal dominant cerebellar ataxias.
Cagnoli C; Stevanin G; Brussino A; Barberis M; Mancini C; Margolis RL; Holmes SE; Nobili M; Forlani S; Padovan S; Pappi P; Zaros C; Leber I; Ribai P; Pugliese L; Assalto C; Brice A; Migone N; Dürr A; Brusco A
Hum Mutat; 2010 Oct; 31(10):1117-24. PubMed ID: 20725928
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive Characterization of an SCA28 Family Caused by a Novel AFG3L2 Gene Mutation.
Szpisjak L; Nemeth VL; Szepfalusi N; Zadori D; Maroti Z; Kalmar T; Vecsei L; Klivenyi P
Cerebellum; 2017 Dec; 16(5-6):979-985. PubMed ID: 28660440
[No Abstract] [Full Text] [Related]
16. SCA28: Novel Mutation in the AFG3L2 Proteolytic Domain Causes a Mild Cerebellar Syndrome with Selective Type-1 Muscle Fiber Atrophy.
Svenstrup K; Nielsen TT; Aidt F; Rostgaard N; Duno M; Wibrand F; Vinther-Jensen T; Law I; Vissing J; Roos P; Hjermind LE; Nielsen JE
Cerebellum; 2017 Feb; 16(1):62-67. PubMed ID: 26868664
[TBL] [Abstract][Full Text] [Related]
17. A novel frameshift mutation in the AFG3L2 gene in a patient with spinocerebellar ataxia.
Musova Z; Kaiserova M; Kriegova E; Fillerova R; Vasovcak P; Santava A; Mensikova K; Zumrova A; Krepelova A; Sedlacek Z; Kanovsky P
Cerebellum; 2014 Jun; 13(3):331-7. PubMed ID: 24272953
[TBL] [Abstract][Full Text] [Related]
18. A novel missense mutation in AFG3L2 associated with late onset and slow progression of spinocerebellar ataxia type 28.
Löbbe AM; Kang JS; Hilker R; Hackstein H; Müller U; Nolte D
J Mol Neurosci; 2014 Apr; 52(4):493-6. PubMed ID: 24293060
[TBL] [Abstract][Full Text] [Related]
19. ATPase Domain AFG3L2 Mutations Alter OPA1 Processing and Cause Optic Neuropathy.
Caporali L; Magri S; Legati A; Del Dotto V; Tagliavini F; Balistreri F; Nasca A; La Morgia C; Carbonelli M; Valentino ML; Lamantea E; Baratta S; Schöls L; Schüle R; Barboni P; Cascavilla ML; Maresca A; Capristo M; Ardissone A; Pareyson D; Cammarata G; Melzi L; Zeviani M; Peverelli L; Lamperti C; Marzoli SB; Fang M; Synofzik M; Ghezzi D; Carelli V; Taroni F
Ann Neurol; 2020 Jul; 88(1):18-32. PubMed ID: 32219868
[TBL] [Abstract][Full Text] [Related]
20. Spinocerebellar ataxia type 28 in a Chinese pedigree: A case report and literature review.
Liu X; Wang L; Chen J; Kang C; Li J
Medicine (Baltimore); 2021 Dec; 100(50):e28008. PubMed ID: 34918652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]